57 reports

  • 2.3 Antifungal Drugs
  • 2.2 Antifungal Agents Overview
  • Antifungal
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SCYNEXIS, Inc.

ANTIFUNGAL DRUGS MARKET ##. ##. ##.

  • Antifungal
  • OTC
  • World

Previously, BCC Research examined the antifungal market in its 2003 report, PHM##A The Market for Antifungal Drugs, in PHM##B Global Markets for Antifungal Agents in PHM##C Antifungal Drugs: Technologies and Global Markets and in the 2014 report PHM##E

  • Antifungal
  • OTC
  • Pharmaceutical
  • World
  • Market Segment

ANTIFUNGAL AGENTS MARKET ##. ##. ##.

  • Antifungal
  • OTC
  • World
  • Antifungal drug resistance
  • Increased funding for antifungal research
  • Antifungal
  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

Inc. ##. ## Pfizer Inc. ##. ## Enzon Pharmaceuticals ##. ## PerkinElmer, Inc., ##. ## Alternaria ##. ## Sigma-Aldrich ##. ## Astellas Pharma Inc List of Tables Table ## Global Antifungal Drugs Market Outlook, By Region (2014-2022) ($MN) Table ## Global Antifungal Drugs Market Outlook, By T

  • Antifungal
  • Asia
  • North America
  • World
  • Forecast

Antifungal Drugs Market By Region, Market Forecast (2013-2025) (US $MN) Table ## Global Antifungal Drugs Market By Drug Type, Market Forecast (2013-2025) (US $MN) Table ## Global Antifungal Drugs Market By Polyenes, Market Forecast (2013-2025) (US $MN) Table ## Global

  • Antifungal
  • OTC
  • United States
  • World
  • Forecast

SYSTEMIC ANTIFUNGAL INFECTION ##. ##. ##.

  • Antifungal
  • OTC
  • World
  • Forecast

ROAPAC ANTIFUNGAL DRUGS MARKET ##.

  • Antifungal
  • OTC
  • Asia
  • Forecast
  • 7: Prescription Antifungal Drugs
  • PRESCRIPTION ANTIFUNGAL FORMULATIONS IN DEVELOPMENT
  • Antifungal
  • Europe
  • World
  • Market Size
  • Galderma S.A.

List of Tables Table ## Global Antifungal infection Therapeutics Market By Region, Market Forecast (2013-2025) (US$ MN) Table ## Global Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN) Table ## Global Antifungal infection Therapeutic

  • Antifungal
  • Europe
  • World
  • Forecast
  • Market Size

FDA ADR reports, 2006-2015 FIG. ## Market restraint relevance analysis (Current & future impact) FIG. ## Penetration & Growth Prospect Mapping FIG. ## Antifungal Drugs PESTLE Analysis FIG. ## Porter’s Five Forces Analysis FIG. ## Antifungal Drugs market drug class outlook key t

  • Antifungal
  • OTC
  • Increased funding for antifungal research
  • Increased funding for antifungal research
  • Antifungal
  • Infectious Disease
  • World
  • Valeant Pharmaceuticals International, Inc.
  • Viamet Pharmaceuticals, Inc.
  • OTHER ANTIFUNGAL AGENTS
  • Prescription Antifungal Drugs
  • Antifungal
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.

Antifungals ##. ##. ##.

  • Antifungal
  • Infectious Disease
  • Europe
  • North America
  • Market Size
  • 4.5 GLOBAL SKIN INFECTIONS MARKET, 2016 - 2026

THE GLOBAL SKIN INFECTIONS MARKET ENCOMPASSES A RANGE OF PRESCRIPTION DRUGS FROM CSSSIS; ANTIBIOTICS (ZYVOX, SIVEXTRO, DALVANCE AND OTHERS)AND FOR ONYCHOMYCOSIS; ANTIFUNGALS (TERBINAFINE FORMULATIONS AND OTHER NCES).

  • Antifungal
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • Galderma
  • Market segmentation by route of administration
  • Antifungal
  • Anacor Pharmaceuticals, Inc.
  • Janssen Biotech, Inc.
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
  • Ketoconazole
  • Amphotericin B Sales Volume and Market Share
  • Anti-Infective
  • Antifungal
  • China
  • Trade
  • Xian-Janssen Pharmaceutical Ltd.
  • Chapter IV
  • Amphotericin B Sales Volume and Market Share
  • Antifungal
  • China
  • Demand
  • Trade
  • Xian-Janssen Pharmaceutical Ltd.
  • Anti-infectives
  • Five: Anti-infectives
  • Antifungal
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • TECHNOLOGY & SYSTEMS
  • SIMILAR INDUSTRIES
  • Antifungal
  • United States
  • Bayer AG
  • GlaxoSmithKline plc
  • Novartis AG
  • 04/17/2017: Cidara Therapeutics to Present Data on Novel Antifungal CD101 at ECCMID and SID Annual Meetings
  • 11/10/2016: Cidara Therapeutics to Present Data on Novel Antifungal CD101 at the Global Joint Conference of ICHS and INFOCUS
  • Antifungal
  • Therapy
  • United States
  • Company
  • Cidara Therapeutics, Inc.
  • antifungal peptide platform technology. This latest grant broadens the commercial applicability of NovaBiotics novel antifungal peptide technology.
  • Mechanism Of Action R&D Progress
  • Antifungal
  • Infectious Disease
  • United States
  • Product Initiative
  • Viamet Pharmaceuticals, Inc.
  • NOVABIOTICS NOVEL ANTIFUNGAL PEPTIDE TECHNOLOGY.
  • HXP-124 - DRUG PROFILE
  • Antifungal
  • Pharmaceutical
  • United States
  • Product Initiative
  • Viamet Pharmaceuticals, Inc.

RADIANT will evaluate two topical formulations of CD##, which is Cidara' s lead antifungal drug candidate.

  • Antifungal
  • Genitourinary System Disease
  • World
  • Product Initiative
  • Cidara Therapeutics, Inc.
  • Apr 17, 2017: Cidara Therapeutics to Present Data on Novel Antifungal CD101 at ECCMID and SID Annual Meetings
  • May 11, 2017: Potent in vitro Activity of SCYNEXIS SCY-078 Against Multidrug-Resistant Fungal Pathogen Candida auris Further Confirmed in an in vitro Study Conducted by the Centers for Disease Control and Prevention
  • Anti-Infective
  • Antifungal
  • Clinical Trial
  • Infectious Disease
  • World
  • Oct 05, 2017: Researchers help develop new antifungal drug
  • Sep 27, 2017: SCYNEXIS to Present Data on Lead Antifungal Candidate SCY-078 at IDWeek 2017
  • Antifungal
  • Infectious Disease
  • United States
  • Product Initiative
  • SCYNEXIS, Inc.
  • Mar 07, 2016: Vical Initiates Phase 1 Trial of Novel Antifungal Compound VL-2397
  • Apr 17, 2017: Cidara Therapeutics to Present Data on Novel Antifungal CD101 at ECCMID and SID Annual Meetings
  • Antifungal
  • Infectious Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • AS-2077715 - DRUG PROFILE
  • compound 1 and substituted derivatives thereof.
  • Antifungal
  • Infectious Disease
  • United States
  • Product Initiative
  • Viamet Pharmaceuticals, Inc.
  • TRANS-UNGUAL DELIVERY OF AR-12, A NOVEL ANTIFUNGAL DRUG
  • POSTER M-856: AR-12, LEAD COMPOUND OF A POTENTIAL NEW CLASS OF ANTIFUNGAL AGENTS
  • Antifungal
  • Infectious Disease
  • United States
  • Product Initiative
  • Arno Therapeutics, Inc.